National Biosafety Framework (NBF) for Tanzania.
Country
Type of law
Policy
Abstract
The National Biosafety Framework (NBF) is a comprehensive document designed to regulate modern biotechnology in Tanzania. It addresses the need for detailed legal, administrative, and policy instruments to minimize biotechnology's risks to human and animal health - with particular attention to food and feeds - and the environment. Additionally, it aims to manage the various concerns, opportunities, and potential side effects, including risks to biodiversity and socio-economic, cultural, and ethical issues associated with modern biotechnology. The framework outlines key elements such as national biosafety policies, regulatory regimes, administrative and decision-making mechanisms, monitoring systems, and public awareness and participation strategies. Furthermore, it focuses on building capacity in risk assessment, risk management, GMO detection, and stakeholder participation in decision-making. The NBF has the following objectives (i) establish a science-based, holistic integrated, efficient, transparent, and participatory administrative and decision-making system so that Tanzania can benefit from modern biotechnology while avoiding or minimizing the inherent environmental, health, and socio-economic risks; (ii) ensure that the research, development, handling, transboundary movement, transit, use, release and management of GMOs are undertaken in a manner that prevents or reduces risks to human and animal health, biological diversity and the environment.
The document addresses four critical areas essential for managing biosafety issues (1) Biosafety Regulatory Regime: It highlights the absence of a single comprehensive law addressing biosafety concerns in Tanzania. Instead, various sectoral laws implicitly cover these issues within their mandates, including plant protection, animal and human health, food quality, environmental protection, and natural resources management (2) Administrative and Decision-Making Mechanisms: It emphasizes the roles of the National Biosafety Focal Point (NBFP), Competent Authorities, and other relevant agencies in regulating modern biotechnology. These entities are responsible for addressing health, environmental, socio-cultural, and ethical impacts. They must formulate directives, coordinate research and development activities, and allocate resources for effective regulation of GM technology and products. The NBFP, ideally the Ministry responsible for the environment, reviews biosafety applications, oversees implementation, disseminates information, liaises with national and international agencies, and ensures compliance with regulations. The National Biosafety Committee (NBC), comprising representatives from various sectors, advises on policies, evaluates biotechnology research, proposes mitigation measures, reviews regulations, and conducts socio-economic impact assessments; (3) Monitoring Systems: It involves collecting data on GMOs to assess their impact on biological diversity, the environment, and human and animal health. Environmental monitoring focuses primarily on confined field trials and the commercial release of GMOs, categorizing effects as severe, moderate, low, negligible, or no harm. For plants, monitoring includes assessing horizontal gene transfer and developing a monitoring and evaluation prospectus. Monitoring occurs at different levels, starting at the project initiation phase and continuing through various stages to ensure compliance. Evaluations are conducted at both formative and final stages. There are two types of monitoring: government-required monitoring to confirm risk assessment assumptions and voluntary monitoring by the applicant for additional information; (4) Mechanisms for Public Awareness, Education, and Participation: It stresses the importance of involving a broad range of stakeholders to promote public awareness and participation, as required by Article 23 of the Cartagena Protocol on Biosafety (CPB). This article mandates the promotion of public awareness, education, and participation in the safe transfer and use of GMOs, considering risks to biodiversity and health. Increasing public awareness and participation is crucial for building consensus, fostering ownership and responsibility, promoting sustainable development, ensuring transparency and accountability, providing balanced information, and harmonizing awareness efforts. Competent Authorities and agencies must promote public awareness, education, and participation in all aspects of GMO research, development, and management, incorporating best practices in their administrative processes.
The document addresses four critical areas essential for managing biosafety issues (1) Biosafety Regulatory Regime: It highlights the absence of a single comprehensive law addressing biosafety concerns in Tanzania. Instead, various sectoral laws implicitly cover these issues within their mandates, including plant protection, animal and human health, food quality, environmental protection, and natural resources management (2) Administrative and Decision-Making Mechanisms: It emphasizes the roles of the National Biosafety Focal Point (NBFP), Competent Authorities, and other relevant agencies in regulating modern biotechnology. These entities are responsible for addressing health, environmental, socio-cultural, and ethical impacts. They must formulate directives, coordinate research and development activities, and allocate resources for effective regulation of GM technology and products. The NBFP, ideally the Ministry responsible for the environment, reviews biosafety applications, oversees implementation, disseminates information, liaises with national and international agencies, and ensures compliance with regulations. The National Biosafety Committee (NBC), comprising representatives from various sectors, advises on policies, evaluates biotechnology research, proposes mitigation measures, reviews regulations, and conducts socio-economic impact assessments; (3) Monitoring Systems: It involves collecting data on GMOs to assess their impact on biological diversity, the environment, and human and animal health. Environmental monitoring focuses primarily on confined field trials and the commercial release of GMOs, categorizing effects as severe, moderate, low, negligible, or no harm. For plants, monitoring includes assessing horizontal gene transfer and developing a monitoring and evaluation prospectus. Monitoring occurs at different levels, starting at the project initiation phase and continuing through various stages to ensure compliance. Evaluations are conducted at both formative and final stages. There are two types of monitoring: government-required monitoring to confirm risk assessment assumptions and voluntary monitoring by the applicant for additional information; (4) Mechanisms for Public Awareness, Education, and Participation: It stresses the importance of involving a broad range of stakeholders to promote public awareness and participation, as required by Article 23 of the Cartagena Protocol on Biosafety (CPB). This article mandates the promotion of public awareness, education, and participation in the safe transfer and use of GMOs, considering risks to biodiversity and health. Increasing public awareness and participation is crucial for building consensus, fostering ownership and responsibility, promoting sustainable development, ensuring transparency and accountability, providing balanced information, and harmonizing awareness efforts. Competent Authorities and agencies must promote public awareness, education, and participation in all aspects of GMO research, development, and management, incorporating best practices in their administrative processes.
Attached files
Web site
Date of text
Repealed
No
Source language
English
Legislation Amendment
No